Fantastic to see our institute on the programme at the Precision Medicine, Genomics and Informatics Theme Symposium.
Huge credit to our speakers driving meaningful progress in cancer research 👏🔬
Last week was an exciting one for the LEGEND Group! We attended NUBI Live, where Lisa and Phoebe gave talks, and Ahmed and Leti presented posters. Nick also presented in the
@nucancer.bsky.social PMGI Symposium. Excellent science with plenty of engaging discussions!
I am deeply honoured to have received two awards from Newcastle University! My sincere thanks to the committee for organising these awards, which recognise the work of technicians. I would also like to thank everyone who nominated me, as well as my team and my PI Lisa Russell for their support.
Two awards, one incredible achievement!
Huge congratulations to NU Cancer’s Camille Drai on winning Outstanding Technician of the Year and Early Career Achievement at the Newcastle University Technician Awards 👏
#NUCancer #NewcastleUniversity #TechnicianAwards
🔬 Thank you to Professor Jonathan Higgins for an excellent #NUCancer Seminar on “Dicentric Chromosomes, Genome Instability, and Cancer.”
Great discussions and insights into chromosome rearrangements and cancer biology.
#CancerResearch #NewcastleUniversity #OncologyResearch
🎉 Great results for the Newcastle Cancer Centre Pharmacology Group at the BPS annual meeting.
🏆 Emma Barlow won Best Clinical Pharmacology Poster and Best Overall Poster
🎤 Daniel Whitaker won Best Oral Presentation (Pharmacogenomics & Toxicology)
Huge congrats to both! 👏🔬
Cancer Research is changing fast, increasingly driven by research innovations.
Hear from our Director of @nucancer.bsky.social, Prof Steve Clifford about how the Centre is advancing cancer research and tackling today's challenges for better diagnosis and treatment tomorrow.
tinyurl.com/wzu6e7uf
🎉 Congrats to Dr Abdullah Malik on securing £21,549 from BASO_ACS & Rosetrees Trust to research radiotherapy in liver cancer, focusing on the immune microenvironment.
The only trainee invited to present at BASO Congress, outstanding work! 👏
#CancerResearch #LiverCancer
Funded PhD opportunity for anyone interested in using cutting-edge chemistry to look at glycan profiles in prostate cancer samples 🙌🏻
The successful student will be based at the University of York with Prof Alison Parkin with the opportunity to carry out a placement at the @nucancer.bsky.social
Incredible energy in the room today, thank you to everyone who came! 🙌
Today’s seminar: the “diabolical duo” in liver cancer; neutrophils + platelets!🩸
Targeting their crosstalk could re-wire the tumour microenvironment + make HCC more responsive to immunotherapy.
🗣️Prof. Derek Mann / Erik Ramon Gil (PhD student)
#LiverCancer #Immunotherapy #Cancer #Research
This Newcastle • Lyon • Paris collaboration will use CRISPR screening & single-cell sequencing in patient-derived models to find smarter drug combinations, with the aim of fast-tracking the most promising ones into early-phase trials.
Congratulations to both!
Fantastic news 🎉
Dr Frederik van Delft & Dr Alistair Poll have been awarded a £353k Children with Cancer UK Research Project Grant (2026–29) to tackle drug-resistant T-cell Acute Lymphoblastic Leukaemia in children. (1/2)
#ChildhoodCancer #TALL #CancerResearch
The Wolfson Childhood Cancer Research Centre at the Herschel Building has earned the Silver LEAF Award for sustainable lab practices! 🥈
Reducing waste, saving energy & going greener every day. 💚
#Sustainability #GreenLabs #LEAFAward #ScienceForGood #NetZero #EcoInnovation
🎓 Great turnout for the first #NUCancer seminar!
Thank you to everyone who joined Prof Christina Halsey for an inspiring talk on improving CNS leukaemia treatmentand reducing neurotoxicity in children.
🧠 Smarter, safer therapies ahead.
#CancerResearch #Leukaemia #Oncology
Their award-winning Microsatellite Instability Plus (MSI-Plus) assay combines the detection of MSI markers and BRAF/RAS mutations in one test — using advanced sequencing technology that works even from minimal DNA samples. 🧬
Read more here:
www.cancerresearchhorizons.com/news-and-eve...
🏆 Huge congratulations to Professor Sir John Burn and his team!
They’ve won the CRUK Research Horizons “Translational Project of the Year” Award, recognising their efforts toward turning cancer research into real-world patient impact. 💙
#CancerResearch #InnovationInOncology
👏 Congrats to Prof Robson & Dr Buskin (NU Cancer), Prof Heer (ICL) & Prof Chimusa (Northumbria) on securing £497K from @prostatecanceruk.bsky.social
to study gene mutations in men of African ancestry, helping to build new, representative disease models.
💙 1 in 8 UK men will develop prostate cancer — but the risk is twice as high for men of African ancestry.
Yet, research in this group is still limited. That needs to change.
#MensHealth #ProstateCancer
Last week on #WorldCancerResearchDay the whole lab and other colleagues from @nucancer.bsky.social turned into bakers to help fundraising for @cancerresearchuk.org, a charity close to us for their commitment to fund groundbreaking projects in cancer research. Lovely seeing the public engaged!
Lisa is the Principal Investigator of the group but she still enjoys spending time in the lab to drive the work to beat blood cancer.
Research is not a solo effort.
It takes teamwork. It takes belief. It takes collaboration.
We know what it takes to beat blood cancer and so does @dr-ahlamq.bsky.social whose work is funded by @bloodcanceruk.bsky.social grant co-led by Lisa & @letimarchetti.bsky.social
#BloodCancerAwarenessMonth
You can read the paper using the QR code below:
🚨New work from the #NUCancer Paediatric Brain Tumour Group shows not all MYC/MYCN-amplified medulloblastomas are the same.
🔹 Some patients face near-incurable disease & need new therapies
🔹 Others can survive long-term with current treatment
#ChildhoodCancer #Medulloblastoma
🧬 Engineered nanobodies binding and stabilizing cancer-mutant p16INK4a—without blocking its CDK6 interaction or cell-cycle arrest function, in press at Structure from Endicott @nucancer.bsky.social and @lauraitzhaki.bsky.social groups!
📖 www.cell.com/structure/fu...
Eleanor’s work, part of the
@colospeed.bsky.social study
network, COLO-COHORT, aims to develop a tool to identify those most at risk of bowel cancer and polyps, and explore links between the microbiome and cancer development.
Great job Eleanor! 👏
Celebrating Excellence: NU Cancer Conference 2025 Prize winner spotlight 🏆
Congrats to Dr. Eleanor Hackney on winning a poster award! Eleanor shined a light on her research around the utility of multiple FIT testing in symptomatic colorectal cancer patients. 🧪
#CancerResearch
Their important research aims to uncover possible causes behind the rise in early onset colorectal cancer (EOCRC) and improve early diagnosis and support services for those affected. 🧬💙
We're proud to see this vital work being recognised and funded! 🙌
🎉 Huge congratulations to Prof. Linda Sharp, Dr. Laura Woods & Dr. Christina Dobson on receiving a £40,000 grant from @HDR_UK North for their 9-month project: “Epidemiology of Early Onset Colorectal Cancer in England” 👏
#ColorectalCancer #EarlyDiagnosis #PublicHealth
🚨 New publication
Prof. Mike Waring & team have advanced micelle-promoted DNA-encoded library synthesis through surfactant optimisation.
Published in @orgbiomolchem.rsc.org.
🔬 Read more: pubs.rsc.org/.../ArticleL...
#CancerResearch #MedicinalChemistry #DrugDiscovery
Images of two individuals looking at the camera. Both are headshots with each person smiling. A woman wears a navy jumper and a silver cross necklace; a man wears a smart, blue and red striped shirt.
Congratulations to two of our scientists, professors Ruth Plummer and Stephen O’Brien, who have been appointed as national cancer drug experts by @england.nhs.uk, leading in ensuring patients have the best possible access to new cancer treatments.
#WeAreNCL